FigureĀ 1.
Low-dose RT improves survival of mice treated with CAR T cells. (A) Schematic diagram of treatment delivery. (B) Bioluminescent imaging (BLI) comparing the outcomes of mice treated with the indicated conditions, quantified in (C) with overall survival charted in (D). 10 000 CAR T cells were used in these studies.